GovChime
Notice ID: 4bdede173938452884e7c2d482f729a8Combined Synopsis/Solicitation

Internet Monitoring Services of FDA Related Products

Archived on August 6, 2024. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
10:00 AM UTC−04:00
Posted
July 18, 2024
Notice type
Combined Synopsis/Solicitation
Agency
Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION

Notice details

Office
FDA OFFICE OF REGULATORY AFFAIRS
Place of performance
Silver Spring, 20903
Last updated
Sep 25, 2026

Identifiers

Solicitation number
75F40124Q00348
Notice ID
4bdede173938452884e7c2d482f729a8

Description

**AMENDMENT 2** **Please see updated Attachment_A_SOW_Amendment2, Attachment_B_PricingExcelWorkbook_Amendment2, Attachment_C_SOL_RFQ_Amendment2, and QA_FDA OCI Internet Monitoring Services_75F40124Q00348 - The purpose of this amendment is to provide responses to questions submitted by interested vendors as well as revise ALL attachments associated.** FDA is responsible for regulating products to ensure the safety of foods, prescription and over-the-counter drugs, biological products such as vaccines and blood, medical devices, cosmetics, radiation-emitting products, and more. Since 1993, Office of Criminal Investigation (OCI) has investigated thousands of criminal schemes involving the distribution of potentially dangerous FDA-regulated products. These investigations have involved a wide variety of criminal conduct, including street level distribution of counterfeit, unapproved, and designer drugs, major organized illicit diversion of prescription drugs, fraudulent schemes involving ineffective AIDS, cancer, and Alzheimer cures, large scale product substitution conspiracies, application and clinical investigator fraud, and health frauds involving harmful FDA-regulated drugs and medical devices. As FDA’s criminal law enforcement arm, OCI protects the American public by conducting criminal investigations of illegal activities involving FDA-regulated products, arresting those responsible, and bringing them before the Department of Justice for prosecution. The Food and Drug Administration (FDA) requires contractor support to further its on-going efforts to counter the widespread illicit trafficking and/or marketing of FDA-regulated products over the Internet. These products include prescription drugs; dietary supplements; tobacco; medical devices; blood and biologics; vaccines; cosmetics; radiation-emitting products; animal and veterinary medicines; and foods.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

No documents available.

Lifecycle

Solicitation:75F40124Q00348
  1. Combined Synopsis
  1. 3×
    Combined SynopsisCurrentJul 8, 2024

    Internet Monitoring Services of FDA Related Products

    Notice 4bdede173938452884e7c2d482f729a8 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75F40124Q00348

Archive Date

Aug 6, 2024

Office Address

Silver Spring, MD, 20993